Viewing Study NCT07006792


Ignite Creation Date: 2025-12-24 @ 3:35 PM
Ignite Modification Date: 2026-03-02 @ 4:09 AM
Study NCT ID: NCT07006792
Status: RECRUITING
Last Update Posted: 2025-12-18
First Post: 2025-05-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to See How Well Lebrikizumab Works in Adults and Adolescents With Moderate Atopic Dermatitis (Eczema) and High Itch Burden
Sponsor: Eli Lilly and Company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module